CHELMSFORD, Mass., May 14, 2020 /PRNewswire/ -- Brooks Automation, Inc. (Nasdaq: BRKS) announced today that company management will participate in the UBS Virtual Global Healthcare Conference on Wednesday, May 20, 2020 at 1:20 p.m. ET. The 40-minute session will be webcast live via the Brooks investor relations website at www.brooks.investorroom.com/events.
About Brooks Automation Brooks (Nasdaq: BRKS) is a leading provider of life science sample-based solutions and semiconductor manufacturing solutions worldwide. The Company's Life Sciences business provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Brooks Life Sciences' GENEWIZ division is a leading provider of DNA gene sequencing and gene synthesis services. With over 40 years as a partner to the semiconductor manufacturing industry, Brooks is a provider of industry-leading precision vacuum robotics, integrated automation systems and contamination control solutions to the world's leading semiconductor chip makers and equipment manufacturers. Brooks is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia. For more information, visit www.brooks.com.
Mark Namaroff Director, Investor Relations Brooks Automation 978.262.2635 [email protected]